Department of Life Sciences and Biotechnology, University of Ferrara, Ferrara, Italy.
Laboratorio RAMSES, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Nucleic Acid Ther. 2020 Jun;30(3):164-174. doi: 10.1089/nat.2019.0825. Epub 2020 Feb 17.
Sulforaphane (SFN) is one of most important dietary constituents of broccoli () and other cruciferous vegetables, which have been reported to exhibit health benefits, including prevention and therapy of cancer, such as colorectal carcinoma (CRC). The objective of this study was to determine whether the anticancer effect of SFN on colon cancer HT-29 cell line could be improved by the combined treatment with molecules inhibiting microRNAs (miRNAs) involved in CRC. As miRNA inhibiting molecules we focused on peptide-nucleic acids (PNAs). As miRNA to be targeted, miR-15b-5p was selected on the basis of several information present in the literature and confirming that miR-15b-5p is overexpressed in colon cancer patients, and that its targeting decreases cell migration and metastasis in colorectal cancer. In this article, we described for the first time the efficacy of targeting miR-15b-5p by using a PNA against miR-15b-5p (R8-PNA-a15b), functionalized with an octoarginine peptide (R8) for maximizing cellular uptake. The miR-15b-5p downregulation in the colon cancer HT-29 cell line was associated with inhibition of cell growth and activation of the proapoptotic pathway, demonstrated by a sharp increase of late apoptotic cells in HT-29-treated cell populations. A second conclusion of this study is that the R8-PNA-a15b might be proposed in "combo-therapy" associated with SFN. To our knowledge, no report is available in the literature on a combination between SFN and miRNA-targeting molecules. Our data demonstrate that this combined treatment leads to a very high proportion of apoptotic HT-29 cells (over 85%), a value higher than the sum of the values of apoptotic cells obtained after singularly administered regents (either SFN or R8-PNA-a15b).
萝卜硫素 (SFN) 是西兰花()和其他十字花科蔬菜中最重要的膳食成分之一,据报道具有健康益处,包括预防和治疗癌症,如结直肠癌(CRC)。本研究的目的是确定 SFN 对结肠癌细胞 HT-29 系的抗癌作用是否可以通过与抑制 CRC 中涉及的 microRNAs (miRNAs) 的分子联合治疗来改善。作为 miRNA 抑制分子,我们专注于肽核酸 (PNA)。作为靶向 miRNA,选择 miR-15b-5p 是基于文献中存在的一些信息,并证实 miR-15b-5p 在结肠癌患者中过度表达,并且其靶向作用可降低结直肠癌中的细胞迁移和转移。在本文中,我们首次描述了使用针对 miR-15b-5p 的 PNA(R8-PNA-a15b)靶向 miR-15b-5p 的功效,该 PNA 针对 miR-15b-5p 进行了功能化,并用八精氨酸肽(R8)进行了功能化,以最大限度地提高细胞摄取率。miR-15b-5p 在结肠癌细胞 HT-29 系中的下调与细胞生长的抑制和促凋亡途径的激活相关,这通过 HT-29 处理的细胞群体中晚期凋亡细胞的急剧增加得到证明。本研究的第二个结论是,R8-PNA-a15b 可与 SFN 一起提出用于“联合治疗”。据我们所知,文献中尚无关于 SFN 与 miRNA 靶向分子联合使用的报道。我们的数据表明,这种联合治疗导致非常高比例的 HT-29 细胞凋亡(超过 85%),这一数值高于单独给予 SFN 或 R8-PNA-a15b 时获得的凋亡细胞值的总和。